Literature DB >> 20410628

Cytotoxicity and utility of 1-indanone in the synthesis of some new heterocycles.

Bahira Hegazi1, Hanan Ahmed Mohamed, Kamal Mohamed Dawood, Farid Abdel-Rahem Badria.   

Abstract

Benzo[d]imidazole 3 and 1,2,4-triazin-5(2H)-one 6 were prepared by the reaction of starting ethyl (3-hydroxy-1H-inden-2-yl)(oxo)-acetate 2 with o-phenylenediamine and thiosemicarbazide respectively. Reaction of 1,4-dihydro-1-phenylindeno[1,2-c]pyrazole-3-carbohydrazide 8 with phenylisothiocyanate gave thiosemicarbazide 9, and its reaction with chloroacetic acid or phenacylbromides led to the formation of thiazolidinone-4-one 10 or 1,3-thiazoles 12a, b. The reactivity of hydrazide 8 towards fluorinated aldehyde, phthalic anhydride, and hydrazonoyl chlorides 15a, b was studied to give fluorinated hydrazones, imide bis-hydrazones 13-16. The newly synthesized compounds were screened for their cytotoxic activities and compounds 6, 8, 9 and 10 were found the most potentially cytotoxic. The detailed synthesis, spectroscopic and biological data are reported.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410628     DOI: 10.1248/cpb.58.479

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

Review 1.  Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.

Authors:  Dmytro Havrylyuk; Olexandra Roman; Roman Lesyk
Journal:  Eur J Med Chem       Date:  2016-02-16       Impact factor: 6.514

2.  Design and synthesis of new bis(1,2,4-triazolo[3,4-b][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition.

Authors:  Fatma M Thabet; Kamal M Dawood; Eman A Ragab; Mohamed S Nafie; Ashraf A Abbas
Journal:  RSC Adv       Date:  2022-08-19       Impact factor: 4.036

3.  Pyrazole carbohydrazide derivatives of pharmaceutical interest.

Authors:  Luiza Rosaria Sousa Dias; Raquel Rocha Silva Salvador
Journal:  Pharmaceuticals (Basel)       Date:  2012-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.